Entremed (ENMD)

[nottadoc2]

From the ASCO AI forum I previously linked today:

'Indeed, in patients who have self-administered endostatin, tumor regression has occurred slowly and many patients are now asymptomatic. The failure of clinical trials that have evaluated these compounds arises because in clinical trials these patients would be considered as nonresponders."

I don't know whether "MANY PATIENTS" is Dr. F's phrase or that of whoever was summarizing his remarks.

The Chiunese folks apparently don't consider these patients as "nonresponders". Maybe after American cancer patients start going to China for their medical treatment, we can start making clothes for the Chinese market.